This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Benign neoplasm: Eye, unspecified
CD2_EYE_NOS
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
160 |
4. Check minimum number of eventsNone |
160 |
5. Include endpointsNone |
160 |
6. Filter based on genotype QC (FinnGen only) |
158 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D31
- Name in latin
- Neoplasma benignum oculi non specificatum
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Eye, unspecified
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of eye and adnexa
- Benign neoplasms
- Neoplasms
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 158 | 103 | 55 |
| Unadjusted period prevalence (%) | 0.03 | 0.04 | 0.03 |
| Median age at first event (years) | 57.28 | 55.50 | 60.60 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 160
- Matched controls
- 1600
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D31.9
ICD-10 Finland
Benign neoplasm: Eye, unspecified
+∞
165.8
129
*
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
6.9
14.3
24
40
CBB30
NOMESCO Finland
Excision of lesion of eyelid
12.6
13.6
24
22
CBB99
NOMESCO Finland
Other excision or destruction of lesion of eyelid
128.9
11.6
12
*
2240A
ICD-9 Finland
Benign neoplasm of eye, Eyeball, except conjunctiva, cornea, retina and choroid
+∞
10.5
10
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.0
8.6
47
193
2248X
ICD-9 Finland
Benign neoplasm of eye, Other specified parts of eye
+∞
8.4
8
*
CD2S4
NOMESCO Finland
Photography of eye
47.3
7.8
9
*
CBA10
NOMESCO Finland
Biopsy of eyelid
26.5
7.7
10
*
CFC00
NOMESCO Finland
Excision of lesion of conjunctiva
26.5
7.7
10
*
3401
FHL
Removal of local modification or taking a specimen in the operating room
+∞
7.3
7
*
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
6.5
6.5
16
27
D31.3
ICD-10 Finland
Benign neoplasm: Choroid
11.7
6.4
11
10
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
26
128
2.23
3.13
2.0
1.9
1.33
1.41
%
0.28
20
113
9
31
3.01
2.11
1.3
1.2
—
—
—
0
0
6
15
4.11
2.06
1.5
1.3
—
—
—
0
0
9
32
2.92
2.03
1.3
1.3
—
—
—
0
0
29
177
1.78
1.93
3.6
2.7
26.00
23.12
%
0.26
24
152
70
536
1.54
1.92
3.9
4.0
62.40
41.86
ng/l
0.24
38
378
6
18
3.42
1.76
2.2
1.7
11.05
208.91
u/ml
—
6
18
83
682
1.45
1.52
9.7
6.6
1.21
1.22
mmol/l
0.55
71
584
6
21
2.93
1.52
1.5
1.7
—
—
—
0
0
46
337
1.51
1.50
1.6
1.5
17.95
21.59
nmol/l
1.01
35
276
6
22
2.79
1.45
1.5
1.8
—
—
—
0
0
22
136
1.72
1.42
5.1
3.7
—
—
—
0
0
9
41
2.26
1.39
1.1
1.3
0.22
0.22
g/l
—
9
41
9
42
2.21
1.36
1.2
1.4
1.16
1.10
g/l
—
9
42
115
1017
1.46
1.35
3.8
4.1
15.17
14.93
pmol/l
0.48
101
913
5
18
2.83
1.29
1.8
1.9
—
—
—
0
0
58
458
1.42
1.27
5.9
3.5
2.31
2.36
mmol/l
1.71
52
408
8
37
2.22
1.23
1.5
2.1
—
—
—
0
0
8
38
2.16
1.20
1.4
2.0
—
—
—
0
0
6
26
2.36
1.20
2.0
1.7
—
—
—
0
0
6
26
2.36
1.20
1.3
2.3
—
—
—
0
0
6
26
2.36
1.20
1.5
1.8
—
—
—
0
0
6
26
2.36
1.20
1.3
2.3
—
—
—
0
0
5
22
2.31
1.04
1.0
1.0
—
—
—
0
0
5
22
2.31
1.04
1.6
1.8
—
—
—
0
0
89
776
1.33
0.99
16.2
9.9
3.36
4.00
e9/l
2.93
83
681
138
1291
1.50
0.97
4.4
4.7
5.92
5.94
mmol/l
0.05
125
1174
28
204
1.45
0.93
2.1
2.1
—
—
—
0
0
6
30
2.04
0.88
1.5
1.9
—
—
—
0
0
8
45
1.82
0.85
1.6
1.9
—
—
—
0
0
32
246
1.38
0.80
4.2
3.6
629.65
94.94
ng/l
0.50
25
187
37
293
1.34
0.78
2.7
2.3
1.15
1.04
mg/l
0.14
28
228
14
92
1.57
0.75
3.5
5.7
440.00
290.88
ng/l
0.33
14
80
146
1396
1.52
0.74
21.4
17.0
83.55
76.21
umol/l
1.27
146
1396
48
398
1.29
0.73
3.9
3.6
1.97
8.74
mg/mmol
2.92
31
245
7
39
1.83
0.73
2.1
1.6
—
—
—
0
0
9
57
1.61
0.72
4.7
2.2
—
—
—
0
0
5
26
1.95
0.71
2.2
1.7
253.80
249.35
u/ml
—
5
17
7
44
1.62
0.66
1.0
1.6
—
—
—
0
0
7
44
1.62
0.66
1.0
1.2
—
—
—
0
0
63
548
1.25
0.65
2.3
1.9
89.42
95.14
pmol/l
0.41
34
279
109
1013
1.24
0.58
5.1
4.1
16.06
12.55
mm/h
1.21
103
918
70
623
1.22
0.57
9.2
5.6
1.21
1.22
mmol/l
0.60
63
566
17
125
1.40
0.56
11.5
3.9
1.89
2.36
mmol/l
0.24
11
99
11
158
0.67
0.56
8.9
8.0
—
—
—
0
0
9
59
1.56
0.56
1.9
1.7
—
—
—
0
0
10
66
1.55
0.54
2.4
1.9
—
—
—
0
0
12
84
1.46
0.51
1.9
1.6
—
—
—
0
0
130
1239
1.26
0.50
4.8
4.8
1.82
1.94
mu/l
0.69
120
1120
7
47
1.51
0.48
1.4
1.4
12.79
29.45
iu/l
—
7
41
132
1263
1.26
0.47
17.9
13.5
78.83
79.56
ml/min/173m2
0.14
115
1048
18
139
1.33
0.46
1.9
1.9
—
—
—
0
0
32
377
0.81
0.45
4.6
4.0
0.00
0.00
estimate
-0.00
16
136
61
547
1.19
0.44
2.2
2.4
79.20
77.48
nmol/l
0.19
53
476
68
616
1.18
0.44
11.9
12.7
1.20
1.25
inr
0.21
21
181
5
33
1.53
0.41
2.8
1.8
—
—
—
0
0
0
15
0.00
0.41
0.0
4.1
—
90.45
—
0
15
0
15
0.00
0.41
0.0
1.3
—
10.07
—
0
15
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
32
272
1.22
0.40
4.3
4.3
21.55
20.49
%
0.11
15
133
0
19
0.00
0.39
0.0
1.4
—
235.77
—
0
19
5
36
1.40
0.38
5.6
2.0
—
—
—
0
0
9
71
1.28
0.37
1.8
1.8
—
—
—
0
0
6
43
1.41
0.35
1.5
2.0
—
—
—
0
0
24
202
1.22
0.33
3.1
3.0
0.79
0.71
ug/l
0.14
17
139
33
375
0.85
0.32
1.7
1.6
1.17
1.36
mmol/l
1.10
24
312
150
1470
1.33
0.31
29.9
21.2
38.79
39.85
%
1.04
141
1384
150
1470
1.33
0.31
29.7
21.4
4.38
4.44
e12/l
0.66
150
1427
14
173
0.79
0.30
5.8
4.7
31.63
32.68
%
—
8
114
150
1471
1.32
0.29
30.2
21.4
131.19
133.97
g/l
1.51
150
1445
12
94
1.30
0.29
6.1
7.3
4.92
5.00
kpa
0.16
12
89
31
272
1.17
0.29
2.0
1.7
1003.84
1162.76
nmol/l
0.29
20
210
17
141
1.23
0.27
2.0
2.0
—
—
—
0
0
25
219
1.17
0.24
2.5
3.0
2.00
2.77
e6/l
0.28
15
122
5
37
1.36
0.24
1.2
1.1
—
—
—
0
0
5
39
1.29
0.23
1.2
1.2
—
—
—
0
0
28
312
0.88
0.21
3.9
2.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
5.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.7
—
5.96
—
0
12
0
14
0.00
0.20
0.0
1.6
—
13.86
—
0
14
6
51
1.18
0.19
2.2
1.9
—
—
—
0
0
86
824
1.09
0.19
3.4
3.0
—
—
—
0
0
10
81
1.25
0.19
1.7
3.9
4.55
4.46
pmol/l
—
10
72
11
132
0.82
0.19
3.8
1.8
—
—
—
0
0
8
68
1.19
0.17
4.3
3.9
23.57
24.87
mmol/l
—
8
68
37
399
0.91
0.17
3.5
2.9
0.23
0.45
e6/l
0.62
27
300
9
106
0.84
0.13
1.4
1.7
—
—
—
0
0
70
676
1.06
0.11
6.2
5.3
0.00
0.00
estimate
-0.00
17
143
83
806
1.06
0.11
6.3
4.0
6.75
6.52
mmol/l
0.50
78
749
10
115
0.86
0.11
6.7
4.8
112.70
119.48
g/l
—
10
115
65
627
1.06
0.10
2.9
2.6
—
—
—
0
0
51
532
0.94
0.10
4.6
4.0
—
—
—
0
0
5
43
1.17
0.10
11.0
2.9
186.00
193.30
%
—
5
43
5
48
1.04
0.09
1.6
1.5
—
—
—
0
0
6
54
1.12
0.09
3.0
2.2
—
—
—
0
0
6
57
1.05
0.08
1.8
3.5
15.67
2574.80
u/ml
—
6
49
5
61
0.81
0.08
11.8
4.4
25.60
24.06
mmol/l
—
5
61
7
67
1.05
0.08
6.1
2.4
1.07
1.24
%
—
7
67
70
681
1.05
0.08
4.2
3.8
0.00
0.00
estimate
-0.00
18
147
37
354
1.06
0.07
3.5
2.9
356.77
7846.45
umol/l
1.98
31
304
7
83
0.84
0.07
1.4
1.3
—
—
—
0
0
31
297
1.05
0.05
1.2
1.2
7.24
1.28
u/ml
—
8
84
30
288
1.05
0.05
2.0
1.8
403.72
476.44
pmol/l
0.78
25
241
130
1288
1.05
0.05
4.8
4.5
4.78
4.66
mmol/l
0.69
119
1193
90
888
1.03
0.04
3.7
3.0
48.43
44.58
u/l
0.17
80
831
49
498
0.98
0.01
3.4
3.1
—
—
—
0
0
69
682
1.02
0.01
4.3
3.9
0.00
0.00
estimate
-0.00
17
132
22
227
0.96
0.01
1.5
1.4
—
—
—
0
0
22
227
0.96
0.01
1.2
1.3
46.53
7.63
u/ml
—
7
81
24
233
1.04
0.01
1.4
1.4
—
—
—
0
0
24
233
1.04
0.01
2.6
2.7
0.69
1.17
e6/l
0.38
14
134
123
1237
0.98
0.01
6.3
5.6
40.21
39.82
mmol/mol
0.16
113
1152
24
244
0.98
0.00
1.2
1.2
17.44
30.26
iu/ml
1.02
14
85
134
1343
0.99
0.00
20.2
14.5
20.34
23.86
mg/l
0.60
109
1070
128
1283
0.99
0.00
4.7
4.5
1.49
1.49
mmol/l
0.03
114
1176
125
1245
1.02
0.00
4.3
4.0
1.32
1.30
mmol/l
0.14
111
1137
56
565
0.99
0.00
9.9
4.8
34.39
35.55
g/l
0.81
51
531
12
118
1.02
0.00
3.1
1.7
—
—
—
0
0
132
1318
1.01
0.00
5.4
5.1
2.88
2.73
mmol/l
1.08
121
1209
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
55.59
—
0
7
0
7
0.00
0.00
0.0
1.1
—
0.30
—
0
7
0
7
0.00
0.00
0.0
1.1
—
20.96
—
0
7
0
9
0.00
-0.00
0.0
3.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
7
71
0.99
-0.00
1.6
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
7.80
—
0
6
7
69
1.02
-0.00
1.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
3.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.5
—
16.80
—
0
6
6
68
0.88
-0.00
3.0
3.8
54.82
47.13
%
—
6
68
0
6
0.00
-0.00
0.0
1.0
—
103.83
—
0
6
0
8
0.00
-0.00
0.0
3.6
—
61.63
—
0
8
0
8
0.00
-0.00
0.0
1.0
—
8.93
—
0
8
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_EYE_NOS – Benign neoplasm: Eye, unspecified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).